Sirolimus for Nosebleeds in HHT
Conditions: Hereditary Hemorrhagic Telangiectasia; Nosebleeds; Epistaxis Intervention: Drug: Sirolimus Sponsors: Unity Health Toronto; National Institutes of Health (NIH) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Epistaxis (Nosebleeds) | Research